Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Klotho Is Neuroprotective in the Superoxide Dismutase (SOD1G93A) Mouse Model of ALS.

Zeldich E, Chen CD, Boden E, Howat B, Nasse JS, Zeldich D, Lambert AG, Yuste A, Cherry JD, Mathias RM, Ma Q, Lau NC, McKee AC, Hatzipetros T, Abraham CR.

J Mol Neurosci. 2019 Oct;69(2):264-285. doi: 10.1007/s12031-019-01356-2. Epub 2019 Jun 27.

PMID:
31250273
2.

SOD1-positive aggregate accumulation in the CNS predicts slower disease progression and increased longevity in a mutant SOD1 mouse model of ALS.

Gill C, Phelan JP, Hatzipetros T, Kidd JD, Tassinari VR, Levine B, Wang MZ, Moreno A, Thompson K, Maier M, Grimm J, Gill A, Vieira FG.

Sci Rep. 2019 Apr 30;9(1):6724. doi: 10.1038/s41598-019-43164-z.

3.

The ALS-inducing factors, TDP43A315T and SOD1G93A, directly affect and sensitize sensory neurons to stress.

Vaughan SK, Sutherland NM, Zhang S, Hatzipetros T, Vieira F, Valdez G.

Sci Rep. 2018 Nov 8;8(1):16582. doi: 10.1038/s41598-018-34510-8.

4.

CuATSM efficacy is independently replicated in a SOD1 mouse model of ALS while unmetallated ATSM therapy fails to reveal benefits.

Vieira FG, Hatzipetros T, Thompson K, Moreno AJ, Kidd JD, Tassinari VR, Levine B, Perrin S, Gill A.

IBRO Rep. 2017 Mar 12;2:47-53. doi: 10.1016/j.ibror.2017.03.001. eCollection 2017 Jun.

5.

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS.

Hatzipetros T, Kidd JD, Moreno AJ, Thompson K, Gill A, Vieira FG.

J Vis Exp. 2015 Oct 6;(104). doi: 10.3791/53257.

6.

Guanabenz Treatment Accelerates Disease in a Mutant SOD1 Mouse Model of ALS.

Vieira FG, Ping Q, Moreno AJ, Kidd JD, Thompson K, Jiang B, Lincecum JM, Wang MZ, De Zutter GS, Tassinari VR, Levine B, Hatzipetros T, Gill A, Perrin S.

PLoS One. 2015 Aug 19;10(8):e0135570. doi: 10.1371/journal.pone.0135570. eCollection 2015.

7.

Degeneration of proprioceptive sensory nerve endings in mice harboring amyotrophic lateral sclerosis-causing mutations.

Vaughan SK, Kemp Z, Hatzipetros T, Vieira F, Valdez G.

J Comp Neurol. 2015 Dec 1;523(17):2477-94. doi: 10.1002/cne.23848. Epub 2015 Jul 21.

8.

C57BL/6J congenic Prp-TDP43A315T mice develop progressive neurodegeneration in the myenteric plexus of the colon without exhibiting key features of ALS.

Hatzipetros T, Bogdanik LP, Tassinari VR, Kidd JD, Moreno AJ, Davis C, Osborne M, Austin A, Vieira FG, Lutz C, Perrin S.

Brain Res. 2014 Oct 10;1584:59-72. doi: 10.1016/j.brainres.2013.10.013. Epub 2013 Oct 18.

PMID:
24141148
9.
10.

Supplemental Content

Loading ...
Support Center